Smoking reduction at midlife and lifetime mortality risk in men: A prospective cohort study

American Journal of Epidemiology

Volumn 175, Issue 10, 2012, Pages 1006-1012

  Gerber, Yariv ^a   Myers, Vicki ^b   Goldbourt, Uri ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

cardiovascular diseases; cohort studies; lifetime risk; longevity; mortality; risk reduction behavior; smoking; smoking reduction

Indexed keywords

BASELINE SURVEY; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HEALTH RISK; LIFE EXPECTANCY; LONGEVITY; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL;

ADULT; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; ISRAEL; LIFE EXPECTANCY; MALE; MORTALITY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SURVIVAL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK REDUCTION BEHAVIOR; SELF REPORT; SMOKING; SMOKING CESSATION;

ISRAEL;

EID: 84861363002     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr466     Document Type: Article

References (39)

1. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328(7455):1519. (doi:10.1136/bmj.38142.554479.AE).
2. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: Office on Smoking and Health, Centers for Disease Control and Prevention, US Department of Health and Human Services; 2004.
3. Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet. 1975;1(7904):415-420.
4. Kenfield SA,Wei EK, Rosner BA, et al. Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tob Control. 2010;19(3):248-254.
5. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services; 2010.
6. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498- 1504. (Pubitemid 27216360)
7. Bell K, McCullough L, Greaves L, et al. NICE Rapid Review: The Effectiveness of National Health Service Intensive Treatments for Smoking Cessation in England. London, United Kingdom: National Institute for Health and Clinical Excellence (NICE); 2006.
8. Zhu S, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18(4):305-311. (Pubitemid 30224565)
9. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29-38. (Pubitemid 38142221)
10. Bauld L, Judge K, Platt S. Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control. 2007;16(6):400-404.
11. Dunn NR, Faragher B, Thorogood M, et al. Risk of myocardial infarction in young female smokers. Heart. 1999;82(5):581-583. (Pubitemid 29515453)
12. US Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease. A Report of the Surgeon General. Rockville, MD: Office on Smoking and Health, Public Health Service, US Department of Health and Human Services; 1983.
13. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control. 2006;15(6):472-480. (Pubitemid 44935575)
14. Joseph AM, Hecht SS, Murphy SE, et al. Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial. Nicotine Tob Res. 2008;10(3):471-481. (Pubitemid 351385828)
15. Godtfredsen NS, Holst C, Prescott E, et al. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol. 2002; 156(11):994-1001. (Pubitemid 35396928)
16. Godtfredsen NS, Osler M, Vestbo J, et al. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health. 2003;57(6):412-416. (Pubitemid 36713002)
17. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption A systematic review. Nicotine Tob Res. 2007;9(6):631-646. (Pubitemid 46930313)
18. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294(12):1505-1510. (Pubitemid 41362687)
19. Gerber Y, Rosen LJ, Goldbourt U, et al. Smoking status and long-term survival after first acute myocardial infarction: a population-based cohort study. Israel Study Group on First Acute Myocardial Infarction. J Am Coll Cardiol. 2009;54(25): 2382-2387.
20. Groen JJ, Medalie JH, Neufeld HN, et al. An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Isr J Med Sci. 1968;4(2):177-194.
21. Medalie JH, Kahn HA, Neufeld HN, et al. Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chronic Dis. 1973;26(2):63-84.
22. Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology. 1993;82(2-3):100-121. (Pubitemid 23182022)
23. Anderson JT, Keys A. Cholesterol in serum and lipoprotein fractions; its measurement and stability. Clin Chem. 1956; 2(3):145-159.
24. Kahn HA, Herman JB, Medalie JH, et al. Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis. 1971;23(9):617-629.
25. Eaton CB, Medalie JH, Flocke SA, et al. Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med. 1995;4(4): 323-329.
26. Goldbourt U, Schnaider-Beeri M, Davidson M. Socioeconomic status in relationship to death of vascular disease and late-life dementia. J Neurol Sci. 2007;257(1-2):177-181. (Pubitemid 46856494)
27. Zhang X, Loberiza FR, Klein JP, et al. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed. 2007;88(2):95-101. (Pubitemid 47588441)
28. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387. (Pubitemid 26072233)
29. Wolbers M, Koller MT, Witteman JC, et al. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009;20(4): 555-561.
30. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94(446):496-509.
31. Du Y. Measuring Effects of Risk Factors on Cumulative Incidence and Remaining Lifetime Risk in the Presence of Competing Risks: Biostatistics. Boston, MA: Boston University; 2010.
32. Kelly TN, Gu D, Chen J, et al. Cigarette smoking and risk of stroke in the Chinese adult population. Stroke. 2008;39(6): 1688-1693.
33. Hatsukami DK, Le CT, Zhang Y, et al. Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2355-2358. (Pubitemid 46048290)
34. Godtfredsen NS, Prescott E, Vestbo J, et al. Smoking reduction and biomarkers in two longitudinal studies. Addiction. 2006; 101(10):1516-1522. (Pubitemid 44337776)
35. Hatsukami DK, Kotlyar M, Allen S, et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128(4):2528-2537. (Pubitemid 41507604)
36. Bolliger CT, Zellweger JP, Danielsson T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res. 2002;4(4):433-439. (Pubitemid 35469977)
37. Song YM, Cho HJ. Risk of stroke and myocardial infarction after reduction or cessation of cigarette smoking: a cohort study in Korean men. Stroke. 2008;39(9):2432-2438.
38. Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk A qualitative review. Nicotine Tob Res. 2006;8(6):739-749. (Pubitemid 44842952)
39. Broms U, Korhonen T, Kaprio J. Smoking reduction predicts cessation: longitudinal evidence from the Finnish adult twin cohort. Nicotine Tob Res. 2008;10(3):423-427. (Pubitemid 351385822)